|
|
|
Nephros Inc 
|
7.97 0.19 (0.02%) |
02-24 16:00 |
Open: |
7.75 |
Pre close: |
7.78 |
Target:
|
9.79
|
High: |
7.97 |
Low: |
7.71 |
Resistance:
|
8.38
9.12
|
Volume: |
5,802 |
Market Cap: |
79M |
Support:
|
7.18
5.97
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
8.22
 |
MACD |
MACD(12,26):
|
0.08  |
MA(20): |
8.26  |
Signal(12,26,9): |
0.16  |
MA(100): |
7.24  |
Stochastic Oscillator |
%K(14,3):
|
28.14  |
MA(250): |
7.42  |
%D(3): |
43.87  |
Average Volume(K) |
3-Month: |
1811
|
52-Week |
High:
|
10.00 |
10-Days: |
1567 |
Low: |
4.42 |
RSI |
RSI(14):
|
46.74  |
Change(%): |
-2.8 |
Financials, Statistics and Valuation |
EPS |
-0.480 |
Return on Equity (ttm) |
-43.1 |
Shares Out. (M) |
9.86 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-19.2 |
Shares Float (M) |
4.42 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.97 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-31.5 |
% Held by Institutions |
53.08 |
Forward EPS |
-0.540 |
Gross Profit (p.s.) |
0.617 |
Shares Short (K) |
9 |
Book Value (p.s.) |
0.930 |
EBITDA (p.s.) |
-0.398 |
P/E |
-16.60 |
Sales Per Share |
0.952 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.57 |
Profit Margin |
-44.22 |
Operating Cash Flow
(M) |
-5.01 |
P/S |
8.37 |
Operating Margin |
-43.87 |
Levered Free Cash Flow
(M) |
-3.99 |
P/CF |
-15.69 |
|
|
|
|
|